Merck

155 results

The EU needs to work to make patent protection fairer. It works well for big pharma at present, but not quite so well for patients.  Photograph: iStock

At the international Aids conference earlier this week a UK academic used a chart to point out the profits and tax-avoidance practices of pharmaceutic(...)

Merck’s total sales rose 5.4 per cent to $10.47 billion but  investors  expected bigger gains in market share for the cancer therapy. Photograph: Ralph Orlowski/Reuters

Merck & Co beat quarterly profit estimates on Friday as sales of its blockbuster drug Keytruda overtook rival Bristol-Myers Squibb’s Opdivo, but t(...)

June data on retail spending looks set to confirm a strong first half of the year as a resurgent economy, falling prices and higher personal income see more spending at the till. Photograph: Bryan O’Brien

Monday Results: Ryanair, Alphabet, Whirlpool, Hasbro. Indicators: Euro-zone consumer confidence flash (Jul). Ryanair investors only have to look(...)

The Four Courts. Pharma  giant Merck Sharp and Dohme had last April secured a temporary High Court injunction preventing rival Clonmel Healthcare continuing to sell a version of MSD’s “Inegy” drug. Photograph: Bryan O’Brien

The Court of Appeal has refused to grant an injunction preventing distribution of a generic alternative to a cholesterol-reducing drug at less than on(...)

Eli Lilly & Co: “We are deeply disappointed for the millions suffering from this devastating disease.” Photograph: Simone Baribeau/Bloomberg

Eli Lilly and AstraZeneca ended two late-stage trials of an experimental drug for Alzheimer’s disease after the treatment failed to show any signs of (...)

Pharmaceutical giant Merck Sharp and Dohme (MSD) last month got a temporary High Court injunction preventing rival Clonmel Healthcare from continue to sell a version of MSD’s “Inegy” drug over alleged breach of trademark.

The Court of Appeal will give a decision later on whether to grant an injunction preventing the distribution of a generic alternative to a cholesterol(...)

Merck reported a better-than-expected first-quarter profit on Tuesday, helped by a rise of more than 150 per cent in sales of cancer drug Keytruda.

Drugmaker Merck reported a better-than-expected first-quarter profit on Tuesday, helped by a rise of more than 150 per cent in sales of cancer drug Ke(...)

More than 3,000 representatives from major construction companies, developers and property managers are expected to attend the National Construction Summit on Wednesday. Photograph: Alan Betson

MONDAY Results: McDonalds. Indicators: Euro-zone loan growth (Mar); German retail sales (Mar), inflation (Apr). TUESDAY Results: Trinity Biotec(...)

Floor of NYSE on Monday, April 23th. Photograph: Michael Nagle/Bloomberg

European shares edged up on Monday as a rise in US Treasury yields helped lift bank stocks to nearly five-week highs, more than offsetting a disappoin(...)

MSD has told the court that Clonmel Healthcare, part of Stada AG publicly quoted group based in Germany, is infringing its patent rights. Photograph: Robbie Reynolds

A rival of pharmaceutical giant MSD is trying to sell a generic version of a cholesterol drug for less than one tenth of the price of its product in b(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »